The National Cancer Institute's Office of Cancer Genomics (OCG) aims to advance the understanding of cancer at the molecular level with the ultimate goal of improving clinical outcomes. Through its various innovative and collaborative research programs, OCG fosters cancer genomics research (the systematic analysis of changes in the genomes of tumors) and the rapid translation of the resulting molecular insights into the clinic. Read more about OCG
Sign up to receive updates from OCG, including the e-Newsletter.
May 2013 OCG e-News
In this issue:
OCG will be at the AACR Annual Meeting 2013!
Learn about OCG program research at three different symposiums/sessions.
Analysis of FOXO1 mutations in diffuse large B-cell lymphoma
March 4, 2013
The genetic landscape of high-risk neuroblastoma
January 20, 2013
The molecular genetic makeup of acute lymphoblastic leukemia
December 8, 2012